The Current Ratio as of December 2025 (TTM) for Cullinan Therapeutics, Inc. (CGEM) is 10.45

According to Cullinan Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.45. This represents a change of -8.01% compared to the average of 11.36 of the last 4 quarters.

Cullinan Therapeutics, Inc. (CGEM) Historical Current Ratio (quarterly & annually)

How has CGEM Current Ratio performed in the past?

The mean historical Current Ratio of Cullinan Therapeutics, Inc. over the last ten years is 22.47. The current 10.45 Current Ratio has changed 4.55% with respect to the historical average. Over the past ten years (40 quarters), CGEM's Current Ratio was at its highest in in the June 2021 quarter at 59.98. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Cullinan Therapeutics, Inc. (CGEM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cullinan Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cullinan Therapeutics, Inc. (CGEM) Average Current Ratio

How has CGEM Current Ratio performed in the past?

The current Current Ratio of Cullinan Therapeutics, Inc. (CGEM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cullinan Therapeutics, Inc. (CGEM) Current Ratio vs. Peers

How is CGEM’s Current Ratio compared to its peers?

Cullinan Therapeutics, Inc.’s Current Ratio is greater than Standard BioTools Inc. (4.38), greater than So-Young International Inc. (2.55), greater than ADC Therapeutics S.A. (4.93), less than RAPT Therapeutics, Inc. (12.04), less than CeriBell, Inc. (12.65), greater than Enhabit, Inc. (1.57), greater than Varex Imaging Corporation (3.43), greater than Neumora Therapeutics, Inc. Common Stock (6.85), greater than Omeros Corporation (0.89), less than Bicycle Therapeutics plc (10.66),

Build a custom stock screener for Cullinan Therapeutics, Inc. (CGEM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cullinan Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cullinan Therapeutics, Inc. (CGEM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cullinan Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.